Search results
138 results found
Long readsBlogSome things are just too interesting to reduce to a few hundred words. The PHG Foundation's long read series takes a deeper dive into areas of new science and their implications for health policy
What does ‘good governance’ look like for genome editing?BlogPHG Policy Analyst, Tanya Brigden, usefully summarises the recommendations for the WHO's considerations towards genome editing
Expanding the public and patient role in medical regulationBlogA recent consultation by the UK Medicines and Healthcare products Regulatory Agency (MHRA) indicates a welcome new direction for public and patient involvement (PPI).
Making the UK a science superpower – will policy moves pay off for health?BlogThe recent and abrupt change in Secretary of State for Health for the UK has overshadowed some very significant policy developments over the last week.
Calls to review regulation of direct-to-consumer genetic testingBlogExcellent new report from Science and Technology Committee, which is gratifyingly in line with our own recommendations.
Putting Genome UK into practice: genomic healthcare strategy implementationBlogImplementation plans for the UK’s landmark Genome UK strategy have been released, with specific commitments for all the major players in genomics research and healthcare revealed.
Bringing order to polygenic score reportingBlogInconsistencies in the way polygenic score models are reported could delay their introduction into healthcare.
Genomic surveillance in the roll out of vaccinesBlogViral genome sequencing will be vital during vaccine roll out to ensure they are still effective in the face of ongoing genetic changes to the virus.
A vision for the future of clinical researchBlogDr Philippa Brice dissects new UK government guidance on plans for the future of clinical research across the country.
International lessons for personalised medicineBlogThe benefits of personalised medicine are increasingly recognised around the world, enabled by advances in our ability to obtain and analyse information from genomic and other biomarkers and combine this with other medical information.